Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -1.69% is 92% above its 5-year average of -20.05%, near the high end of its 5-year range (-54.78%–2.67%).
42.93% above its 12-month average of -2.96%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -0.17%.
NET PROFIT MARGIN
-1.69%
NET PROFIT MARGIN AVG TTM
-2.96%
NET PROFIT MARGIN AVG 3Y
-13.87%
NET PROFIT MARGIN AVG 5Y
-20.05%
NET PROFIT MARGIN AVG 10Y
-23.55%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+42.93%
CURRENT VS 3Y AVG
+87.82%
CURRENT VS 5Y AVG
+91.57%
CURRENT VS 10Y AVG
+92.82%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-550.00%
vs the sector median at left
iRhythm Technologies, Inc.
Market Cap
$3.52B
Net Profit Margin
-1.69%
TTM Avg
-2.96%
3Y Avg
-13.87%
5Y Avg
-20.05%
Market Cap
$3.54B
Net Profit Margin
-4612.13%
TTM Avg
-2306.07%
3Y Avg
-1485.27%
5Y Avg
-1076.43%
Market Cap
$3.56B
Net Profit Margin
20.37%
TTM Avg
9.12%
3Y Avg
-3.67%
5Y Avg
-13.14%
Market Cap
$3.48B
Net Profit Margin
-74.75%
TTM Avg
-1986.54%
3Y Avg
-1142.83%
5Y Avg
-820.99%
Market Cap
$3.57B
Net Profit Margin
-229.92%
TTM Avg
-236.29%
3Y Avg
-296.56%
5Y Avg
-337.05%
Market Cap
$3.44B
Net Profit Margin
-6755.78%
TTM Avg
-10397.28%
3Y Avg
-7288.11%
5Y Avg
-5606.97%
Market Cap
$3.64B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.38B
Net Profit Margin
33.42%
TTM Avg
30.07%
3Y Avg
2.48%
5Y Avg
-14.75%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iRhythm Technologies, Inc. (IRTC) | $3.52B | -1.69% | -2.96% | -13.87% | -20.05% |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.54B | -4612.13% | -2306.07% | -1485.27% | -1076.43% |
| Veracyte, Inc. (VCYT)vs › | $3.56B | 20.37% | 9.12% | -3.67% | -13.14% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | -74.75% | -1986.54% | -1142.83% | -820.99% |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.57B | -229.92% | -236.29% | -296.56% | -337.05% |
| Celcuity Inc. (CELC)vs › | $3.47B | 0.00% | 0.00% | 0.00% | 0.00% |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | -6755.78% | -10397.28% | -7288.11% | -5606.97% |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.64B | 0.00% | 0.00% | 0.00% | 0.00% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 33.42% | 30.07% | 2.48% | -14.75% |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-1.2%
Net Profit Margin
-1.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -0.17% |
| 2026-03-31 | -6.99% |
| 2025-12-31 | 2.67% |
| 2025-09-30 | -2.70% |
| 2025-06-30 | -7.62% |
| 2025-03-31 | -19.35% |
| 2024-12-31 | -0.81% |
| 2024-09-30 | -31.30% |
| 2024-06-30 | -13.58% |
| 2024-03-31 | -34.61% |
| 2023-12-31 | -29.20% |
| 2023-09-30 | -21.76% |
| 2023-06-30 | -14.89% |
| 2023-03-31 | -35.10% |
| 2022-12-31 | -17.94% |
| 2022-09-30 | -20.65% |
| 2022-06-30 | -23.42% |
| 2022-03-31 | -54.78% |
| 2021-12-31 | -39.72% |
| 2021-09-30 | -27.78% |
| 2021-06-30 | -21.36% |
| 2021-03-31 | -37.38% |
| 2020-12-31 | -12.25% |
| 2020-09-30 | -6.50% |
| 2020-06-30 | -40.17% |
| 2020-03-31 | -14.27% |
| 2019-12-31 | -29.27% |
| 2019-09-30 | -33.46% |
| 2019-06-30 | -20.45% |
| 2019-03-31 | -17.07% |
| 2018-12-31 | -34.09% |
| 2018-09-30 | -25.30% |
| 2018-06-30 | -34.41% |
| 2018-03-31 | -36.37% |
| 2017-12-31 | -39.56% |
| 2017-09-30 | -26.06% |
| 2017-06-30 | -27.01% |
| 2017-03-31 | -24.74% |
| 2016-12-31 | -33.50% |
| 2016-09-30 | -24.28% |
| 2016-06-30 | -28.19% |
| 2016-03-31 | -47.66% |
| 2015-12-31 | -70.96% |
| 2015-09-30 | -61.49% |
| 2015-06-30 | -58.66% |
| 2015-03-31 | -58.66% |
| 2014-12-31 | -62.62% |
